Crohn’s Disease Diagnostic and Therapeutic Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 150 Category: Industrial Automation Report Code : ME106027
Crohn’s Disease Diagnostic and Therapeutic Market by Product Type (Fecal Test, Flexible Sigmoidoscopy, Magnetic Resonance Imaging, Blood Tests, Colonoscopy, Computerized Tomography, Capsule Endoscopy) Application (Hospital, Clinic) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Crohn’s Disease Diagnostic and Therapeutic Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Crohn's disease is a kind of incendiary gut illness (IBD) that may influence any piece of the gastrointestinal tract from mouth to rear-end. Signs and indications frequently incorporate stomach torment, fever, diarrhea, and weight loss. As the predominance of the disease builds, it is anticipated to drive the Crohn's disease demonstrative and therapeutic market and the expanding interest for brief finding and different manifestations related with the illness requiring singular remedial consideration are expanding the development of the market.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AbbVie
- Salix Pharmaceuticals
- Takeda's Pharmaceutical
- Genetech
- Celgene Corporation
- Pfizer
- Prometheus Laboratories
- Janssen Biotech
- Johnson & Johnson
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Crohn’s Disease Diagnostic and Therapeutic Market , By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Fecal Test
o Flexible Sigmoidoscopy
o Magnetic Resonance Imaging
o Blood Tests
o Colonoscopy
o Computerized Tomography
o Capsule Endoscopy
· Crohn’s Disease Diagnostic and Therapeutic Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
· Crohn’s Disease Diagnostic and Therapeutic Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AbbVie
o Salix Pharmaceuticals
o Takeda's Pharmaceutical
o Genetech
o Celgene Corporation
o Pfizer
o Prometheus Laboratories
o Janssen Biotech
o Johnson & Johnson
· Crohn’s Disease Diagnostic and Therapeutic Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Crohn’s Disease Diagnostic and Therapeutic Market , By Country
o U.S. Crohn’s Disease Diagnostic and Therapeutic Market
o Canada Crohn’s Disease Diagnostic and Therapeutic Market
o Mexico Crohn’s Disease Diagnostic and Therapeutic Market
o Europe
§ Europe Crohn’s Disease Diagnostic and Therapeutic Market , By Country
· Germany Crohn’s Disease Diagnostic and Therapeutic Market
o UK Crohn’s Disease Diagnostic and Therapeutic Market
o France Crohn’s Disease Diagnostic and Therapeutic Market
o Russia Crohn’s Disease Diagnostic and Therapeutic Market
o Italy Crohn’s Disease Diagnostic and Therapeutic Market
o Rest of Europe Crohn’s Disease Diagnostic and Therapeutic Market
o Asia-Pacific
§ Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market , By Country
o China Crohn’s Disease Diagnostic and Therapeutic Market
o Japan Crohn’s Disease Diagnostic and Therapeutic Market
o South Korea Crohn’s Disease Diagnostic and Therapeutic Market
o India Crohn’s Disease Diagnostic and Therapeutic Market
o Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market
o Rest of Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market
o South America
§ South America Crohn’s Disease Diagnostic and Therapeutic Market
o Brazil Crohn’s Disease Diagnostic and Therapeutic Market
o Argentina Crohn’s Disease Diagnostic and Therapeutic Market
o Columbia Crohn’s Disease Diagnostic and Therapeutic Market
o Rest of South America Crohn’s Disease Diagnostic and Therapeutic Market
o Middle East and Africa
§ Middle East and Africa Crohn’s Disease Diagnostic and Therapeutic Market
o Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market
o UAE Crohn’s Disease Diagnostic and Therapeutic Market
o Egypt Crohn’s Disease Diagnostic and Therapeutic Market
o Nigeria Crohn’s Disease Diagnostic and Therapeutic Market
o South Africa Crohn’s Disease Diagnostic and Therapeutic Market
o Rest of MEA Crohn’s Disease Diagnostic and Therapeutic Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Crohn’s Disease Diagnostic And Therapeutic Market, By Product Type
5.1. Introduction
5.2. Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Revenue Share by Product Type (2017-2027)
5.3. Fecal Test
5.3.1. Global Fecal Test Revenue and Growth Rate (2017-2027)
5.4. Flexible Sigmoidoscopy
5.4.1. Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2027)
5.5. Magnetic Resonance Imaging
5.5.1. Global Magnetic Resonance Imaging Revenue and Growth Rate (2017-2027)
5.6. Blood Tests
5.6.1. Global Blood Tests Revenue and Growth Rate (2017-2027)
5.7. Colonoscopy
5.7.1. Global Colonoscopy Revenue and Growth Rate (2017-2027)
5.8. Computerized Tomography
5.8.1. Global Computerized Tomography Revenue and Growth Rate (2017-2027)
5.9. Capsule Endoscopy
5.9.1. Global Capsule Endoscopy Revenue and Growth Rate (2017-2027)
6. Crohn’s Disease Diagnostic And Therapeutic Market, By Application
6.1. Introduction
6.2. Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Market Share by Application (2017-2027)
6.2.1. Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Revenue Share by Application (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Clinic
6.4.1. Global Clinic Revenue and Growth Rate (2017-2027)
7. Crohn’s Disease Diagnostic And Therapeutic Market, By Region
7.1. Introduction
7.2. Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Market Share by Regions
7.2.1. Global Crohn’s Disease Diagnostic And Therapeutic Revenue by Regions (2017-2027)
7.3. North America Crohn’s Disease Diagnostic And Therapeutic by Countries
7.3.1. North America Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2027)
7.3.2. North America Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Crohn’s Disease Diagnostic And Therapeutic by Countries
7.4.1. Europe Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2027)
7.4.2. Europe Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic by Countries
7.5.1. Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Crohn’s Disease Diagnostic And Therapeutic by Countries
7.6.1. South America Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2027)
7.6.2. South America Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic by Countries
7.7.1. Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. AbbVie
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Salix Pharmaceuticals
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Takeda's Pharmaceutical
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Genetech
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Celgene Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Pfizer
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Prometheus Laboratories
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Janssen Biotech
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Johnson & Johnson
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.1. Global Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Crohn’s Disease Diagnostic And Therapeutic Market Forecast by Regions (2017-2027)
9.2.1. North America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.1.1. United States Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.1.2. Canada Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.1.3. Mexico Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2. Europe Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.1. Germany Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.2. France Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.3. UK Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.4. Russia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.5. Italy Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3. Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.1. China Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.2. Japan Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.3. Korea Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.4. India Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.4. South America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.4.1. Brazil Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.4.2. Argentina Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.4.3. Columbia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.4.4. Rest of South America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5. Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.3. Egypt Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.4. Nigeria Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.5. South Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.6. Turkey Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2017-2027)
9.3. Crohn’s Disease Diagnostic And Therapeutic Market Forecast by Product Type (2017-2027)
9.3.1. Crohn’s Disease Diagnostic And Therapeutic Forecast by Product Type (2017-2027)
9.3.2. Crohn’s Disease Diagnostic And Therapeutic Market Share Forecast by Product Type (2017-2027)
9.4. Crohn’s Disease Diagnostic And Therapeutic Market Forecast by Application (2017-2027)
9.4.1. Crohn’s Disease Diagnostic And Therapeutic Forecast by Application (2017-2027)
9.4.2. Crohn’s Disease Diagnostic And Therapeutic Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Fecal Test Revenue and Growth Rate (2017-2018)
Figure Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2018)
Figure Global Magnetic Resonance Imaging Revenue and Growth Rate (2017-2018)
Figure Global Blood Tests Revenue and Growth Rate (2017-2018)
Figure Global Colonoscopy Revenue and Growth Rate (2017-2018)
Figure Global Computerized Tomography Revenue and Growth Rate (2017-2018)
Figure Global Capsule Endoscopy Revenue and Growth Rate (2017-2018)
Table Global Crohn’s Disease Diagnostic And Therapeutic Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Table Global Crohn’s Disease Diagnostic And Therapeutic Revenue by Regions (2017-2018)
Figure North America Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure North America Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2018)
Figure North America Crohn’s Disease Diagnostic And Therapeutic by Countries (2017-2018)
Figure North America Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2018)
Figure United States Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure United States Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Canada Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Mexico Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Europe Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2018)
Figure Europe Crohn’s Disease Diagnostic And Therapeutic by Countries (2017-2018)
Figure Europe Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2018)
Figure Germany Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Germany Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure France Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure UK Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Russia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Italy Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic by Countries (2017-2018)
Figure Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2018)
Figure China Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure China Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Japan Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Korea Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure India Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure South America Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2018)
Figure South America Crohn’s Disease Diagnostic And Therapeutic by Countries (2017-2018)
Figure South America Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Brazil Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Argentina Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Columbia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Rest of South America Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic by Countries (2017-2018)
Figure Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Egypt Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Nigeria Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure South Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Turkey Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2017-2018)
Table AbbVie Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Salix Pharmaceuticals Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Takeda's Pharmaceutical Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Genetech Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Celgene Corporation Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Pfizer Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Prometheus Laboratories Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Janssen Biotech Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Table Johnson & Johnson Crohn’s Disease Diagnostic And Therapeutic Financial Overview
Figure Global Crohn’s Disease Diagnostic And Therapeutic Revenue (Millions USD) and Growth Rate (2018-2025)
Table Crohn’s Disease Diagnostic And Therapeutic Market Forecast by Regions (2018-2025)
Figure North America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure United States Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Canada Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Mexico Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Europe Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Germany Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure France Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure UK Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Russia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Italy Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Rest of Europe Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure China Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Japan Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Korea Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure India Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Southeast Asia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure South America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Brazil Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Argentina Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Columbia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Rest of South America Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Saudi Arabia Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure United Arab Emirates Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Egypt Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Nigeria Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure South Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Turkey Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Crohn’s Disease Diagnostic And Therapeutic Market Forecast (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Forecast by Product Type (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Market Share Forecast by Product Type (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Forecast by Product Type (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Forecast by Application (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Market Share Forecast by Application (2018-2025)
Figure Global Crohn’s Disease Diagnostic And Therapeutic Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|